Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Monastir
About this trial
the study aims to examine the short-term (30 days) effects of olive leaf extract on endothelial function in patients with acute coronary syndrome (ACS).
This investigation will be conducted on patients admitted to the emergency department for ACS. All participants will be screened and included within 24 hours post-ACS event and prior to discharge from the emergency department.
Eligibility criteria
Qualifiers
None
Disqualifiers
Severe LV hypertrophy (>15 mm);
Patients with any evidence of inflammatory or malignant disease.
Patient having valvular heart disease, pacemaker; cardiogenic shock
Patient having any serious non-cardiac disease associated with a life expectancy <1 year
Trial design
Treatments tested in this trial
- Atherolive 500mg/day
- Atherolive 1000/day
- Placbo_Atherolive
Treatment groups
300 Participants
are divided into 3 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov